121 related articles for article (PubMed ID: 6505256)
1. Lymphocyte predominant Hodgkin's disease: clinical presentation and results of treatment.
Russell KJ; Hoppe RT; Colby TV; Burns BF; Cox RS; Kaplan HS
Radiother Oncol; 1984 Jan; 1(3):197-205. PubMed ID: 6505256
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
5. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
6. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
8. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte predominant Hodgkin's disease: pathology and clinical implication.
Franklin J; Tesch H; Hansmann ML; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S39-44. PubMed ID: 9926236
[TBL] [Abstract][Full Text] [Related]
10. Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
Hull MC; Mendenhall NP; Colgan ME
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):161-6. PubMed ID: 11777634
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
Grossman DM; Hanson CA; Schnitzer B
Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
[TBL] [Abstract][Full Text] [Related]
12. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
Tate DJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
[TBL] [Abstract][Full Text] [Related]
13. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic implications of the peculiar clinical characteristics of Hodgkin's disease in clinical stages I-II with isolated neck presentation].
Magrini SM; Cellai E; Papi MG; Pertici M; Lastrucci L; Ponticelli P; Sulprizio S; Biti G
Radiol Med; 1995; 90(1-2):108-12. PubMed ID: 7569074
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
[TBL] [Abstract][Full Text] [Related]
16. [Results of the radiotherapy of Hodgkin's disease (Analysis of cases at Osaka University Hospital)].
Ikeda H; Masaki N; Aozasa K
Gan No Rinsho; 1988 Apr; 34(5):693-7. PubMed ID: 3385935
[TBL] [Abstract][Full Text] [Related]
17. Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease.
Backstrand KH; Ng AK; Takvorian RW; Jones EL; Fisher DC; Molnar-Griffin BJ; Silver B; Tarbell NJ; Mauch PM
J Clin Oncol; 2001 Feb; 19(3):736-41. PubMed ID: 11157025
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
19. Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefit.
Gomez GA; Reese PA; Nava H; Panahon AM; Barcos M; Stutzman L; Han T; Henderson ES
Am J Med; 1984 Aug; 77(2):205-10. PubMed ID: 6380286
[TBL] [Abstract][Full Text] [Related]
20. Are pelvic irradiation and routine staging laparotomy necessary in clinically staged IA and IIA Hodgkin's disease?
Griffin T; Gerdes A; Parker R; Taylor E; Hafermann M; Taylor W; Tesh D
Cancer; 1977 Dec; 40(6):2914-6. PubMed ID: 412583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
